Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank55
5Y CAGR-18.1%
Studio
Year-over-Year Change

Diluted earnings per share

5Y CAGR
-18.1%/yr
Long-term compound
Percentile
P55
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM0.22+159.1%
2024-0.38+20.8%
2023-0.48+44.2%
2022-0.86-1328.6%
20210.07-88.5%
20200.61+113.3%
2019-4.57-243.6%
2018-1.33-191.1%
20171.46+32.7%
20161.10-